Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00598780 · ClinicalTrials.gov registry record
Evaluation of Safety of Levocetirizine in Routine Clinical Practice-non- Interventional Study
A clinical trial of Rhinitis Allergic, Persistent, sponsored by UCB Pharma.
- Completed
- Registry status
- 7,870
- Enrollment target
- 1
- Study location
NCT00598780: Completed study of Rhinitis Allergic, Persistent, sponsored by UCB Pharma.
NCT00598780 is a study of Rhinitis Allergic, Persistent that has completed, run by UCB Pharma. The registered enrollment target is 7,870 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00598780, a study of Rhinitis Allergic, Persistent, has completed, sponsored by UCB Pharma.
- COMPLETED
- Registry status
- 7,870 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate over a period of 6 months the safety and the treatment satisfaction of newly prescribed levocetirizine in patients of age ≥ 2 years with persistent allergic rhinitis.
Conditions Studied
Study Locations (1)
Georgia
- UCB Pharma - Smyrna
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,870 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-09 |
What the finished NCT00598780 record still lists
NCT00598780 is an observational study that tracks outcomes without assigning an intervention. Its 7,870 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Rhinitis Allergic, Persistent appearing as the primary indexed condition, and to 0 interventions.
NCT00598780 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT00598780 about?
NCT00598780 is a clinical study titled "Evaluation of Safety of Levocetirizine in Routine Clinical Practice-non- Interventional Study". To evaluate over a period of 6 months the safety and the treatment satisfaction of newly prescribed levocetirizine in patients of age ≥ 2 years with persistent allergic rhinitis.
What is the current status of trial NCT00598780?
This trial is currently completed. The enrollment target is 7,870 participants. The study started on 2007-09. Estimated completion is 2008-09.
What conditions does trial NCT00598780 study?
This clinical trial studies the following conditions: Rhinitis Allergic, Persistent.
Who is sponsoring clinical trial NCT00598780?
This trial is sponsored by UCB Pharma, which has 100 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00598780 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
- NCT00898638 · 8,000 participants
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
- NCT02240862 · 8,000 participants
The CREST-2 Registry
- NCT03072927 · 8,000 participants
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia